Reentry is a common mechanism for ventricular tachycardia in cardiac sarcoidosis, occurring in both active and inactive phases, which complicates therapy and supports the use of implantable cardioverter-defibrillators.
No takes yet. Share an insight, caveat, or question.
Reentry may predominate in cardiac sarcoidosis VT; hypothesis-generating and should not yet change management.
Furushima et al. (2004) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: